Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Key Players

posted on Aug 31, 2016 10:08PM

Awaken Dormant DNA, Epigenetically
Rob Ranulph Jones
Sep 1, 2016 (Vol. 36, No. 15)

"....Key players in bromodomain epigenetics work, especially as it relates to advanced clinical research, are Resverlogix and Zenith Epigenetics...."

5 Recommendations